Kyle Piskel, Principal Accounting Officer at Adaptive Biotechnologies Corp (ADPT), sold 307 shares at $8.87 ($3K) on 2022-11-16, disclosed to the SEC on 2022-11-17.
Open-market sale of $3k ADPT by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-02-06 | $40K | — | Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |